RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
NCT05557292
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class
Stopped
Drug no longer provided by sponsor
Conditions
Glioblastoma
Recurrent Glioblastoma
Interventions
DRUG:
RMC-5552
Sponsor
Nicholas Butowski
Collaborators
[object Object]
[object Object]